What is Encision?
Encision Inc. is a Boulder, Colorado-based firm that designs and markets advanced surgical instrumentation. The company's core innovation is its Active Electrode Monitoring (AEM) technology, which is engineered to prevent dangerous stray energy burns during minimally invasive procedures. Encision's product portfolio aims to deliver improved surgical performance and value to hospitals across a wide spectrum of minimally invasive surgical applications. The company's pioneering work in AEM technology positions it as a key player in advancing safety standards within surgical practices.
How much funding has Encision raised?
Encision has raised a total of $1.4M across 3 funding rounds:
Debt
$350K
Debt
$533K
Private Equity
$500K
Debt (2020): $350K with participation from PPP
Debt (2021): $533K led by PPP
Private Equity (2025): $500K, investors not publicly disclosed
Key Investors in Encision
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Encision?
With the recent infusion of major strategic capital, Encision is poised for accelerated expansion and further development of its surgical instrumentation portfolio. The enterprise-level funding suggests a focus on scaling operations, enhancing market penetration, and potentially exploring new technological advancements in surgical safety. This strategic investment will likely enable Encision to solidify its market leadership and continue its mission of improving patient outcomes through innovative AEM technology. The company's trajectory indicates a strong emphasis on research and development to maintain its competitive edge in the evolving landscape of minimally invasive surgery.
See full Encision company page
